BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 436897)

  • 1. Studies on cellular immunity in patients with renal carcinoma: radiation-induced inhibition of leukocyte migration.
    Schwarze G; Dietz R; Pappas A
    Eur J Cancer (1965); 1979 Feb; 15(2):205-10. PubMed ID: 436897
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of cell-mediated immunity against human renal carcinoma assessed by the leukocyte migration assay.
    Pappas A; Schwarze G
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):142-50. PubMed ID: 4143237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pre-operative irradiation and tumor-specific immune response in hypernephroid renal carcinoma (author's transl)].
    Dietz R; Schwarze G; Pappas A
    Strahlentherapie; 1979 Jul; 155(7):466-9. PubMed ID: 115119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor-specific immune response of hypernephroid renal carcinoma after in vitro irradiation (author's transl)].
    Dietz R; Schwarze G; Pappas A
    Strahlentherapie; 1979 Nov; 155(11):754-6. PubMed ID: 516095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiation-induced inhibition of in vitro leukocyte migration in patients with hypernephroma].
    Schwarze G; Dietz R; Mannel H; Pappas A
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1227-30. PubMed ID: 417486
    [No Abstract]   [Full Text] [Related]  

  • 6. The dose-related effect of tumour extract on the in vitro migration of leucocytes from patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1975 Apr; 11(4):281-9. PubMed ID: 1095377
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of cellular immunity to renal cell carcinoma.
    Daly JJ; Prout GR; Ahl CA; Lin JC
    J Urol; 1974 Apr; 111(4):448-52. PubMed ID: 4819368
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
    Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
    Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
    Cummings KB; Peter JB; Kaufman JJ
    J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
    [No Abstract]   [Full Text] [Related]  

  • 10. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor specific, cellular immune response in vitro, in patients with hypernephroma].
    Pappas A; Schwarze G; König K; Scheurlen PG
    Verh Dtsch Ges Inn Med; 1974; 80():1633-6. PubMed ID: 4454498
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour-distinctive cellular immunity to renal carcinoma.
    Stjernswärd J; Almgård LE; Franzén S; von Schreeb T; Wadström LB
    Clin Exp Immunol; 1970 Jun; 6(6):963-8. PubMed ID: 5477730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.
    Montie JE; Straffon RA; Deodhar SD; Barna B
    J Urol; 1976 Mar; 115(3):239-42. PubMed ID: 1255882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumour-directed, cell-mediated hypersensitivity detected by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Nov; 12(11):889-98. PubMed ID: 991899
    [No Abstract]   [Full Text] [Related]  

  • 15. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
    Kjoer M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular immunity in Wilm's tumour and neuroblastoma.
    Kumar S; Taylor G; Steward JK; Waghe MA; Pearson D
    Int J Cancer; 1972 Jul; 10(1):36-43. PubMed ID: 4350513
    [No Abstract]   [Full Text] [Related]  

  • 18. [Normal human lymphocyte mediated cytotoxicity against an established cell line (KU-2) derived from human renal cell carcinoma: role to T & B cells as effector (author's transl)].
    Jistukawa S
    Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1623-38. PubMed ID: 311392
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity in renal cell carcinoma-preliminary report.
    Cole AT; Avis I; Fried FA; Avis F
    J Urol; 1976 Mar; 115(3):234-8. PubMed ID: 1255881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary irradiation and tumor specific immune response in hypernephroid kidney cancers].
    Dietz R; Schwarze G; Pappas A
    Strahlentherapie Sonderb; 1981; 76():187-9. PubMed ID: 7029796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.